Global Rx Spending To Hit $1.4tn In 2020, IMS Institute Says
This article was originally published in The Pink Sheet Daily
While two-thirds of pharmaceutical use by volume will be in "pharmerging markets," developed markets will continue to account for the majority of spending due to use of higher-priced brands, IMS Institute for Healthcare Informatics projects. Overall growth will be at slightly lower pace than seen in last five years.
Register for our free email digests: